NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
NovelStem International Total Assets (Quarterly) : 0.0647M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0647M |
| March 31, 2026 | 0.1009M |
| December 31, 2025 | 0.0158M |
| September 30, 2025 | 0.0148M |
| June 30, 2025 | 0.0153M |
| March 31, 2025 | 0.15M |
| December 31, 2024 | 0.1601M |
| September 30, 2024 | 0.1985M |
| June 30, 2024 | 2.338M |
| March 31, 2024 | 2.401M |
| December 31, 2023 | 2.254M |
| September 30, 2023 | 2.019M |
| June 30, 2023 | 2.103M |
| March 31, 2023 | 2.203M |
| December 31, 2022 | 2.286M |
| September 30, 2022 | 2.031M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Protara Therapeutics, Inc. | 176.09M |
| Clene, Inc. | 23.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.097M |
| Shareholders Equity (Quarterly) | -2.032M |
| Debt to Equity Ratio | -0.8748 |
| Current Ratio | 0.0309 |
| Net Debt Paydown Yield | 88.07% |